in each center patients were randomized into two treatment groups , each center using 2 of 6 proposed treatments : ( 1 ) spironolactone and 500 mg na p.d ( 77 patients ) , ( 2 ) spironolactone + furosemide or moduretic ( amiloride + hydrochlorothiazide ) and 500 mg na p.d ( 80 patients ) , ( 3 ) spironolactone + furosemide or moduretic and unrestricted sodium diet ( 86 patients ) , ( 4 ) concentrated ascites reinfusion and 500 mg na p.d .
C0037982
spironolactone
C0003962
ascites